improvement as any more esoteric methods of management [not defined] ."
My own non-esoteric common sense tells me that severely disabled stroke patients need and respond to intensive rehabilitation, started on the day of onset of the stroke and provided by an expert and committed team of doctor, nurse, physiotherapist, occupational therapist, speech therapist, and social worker.' Your reference to "physical treatment . . . unenthusiastically applied at infrequent intervals over a long period in a vain attempt to achieve unrealistic goals" certainly does not describe what happens in the all-too-few stroke rehabilitation units and in the many departments of geriatric medicine where stroke rehabilitation is taken seriously; nor do the staff of such units need to be reminded that "contractures, stiff and painful shoulders, bed sores, and loss of morale may be preventable." (And you might have added incontinence, loss of balance, muscle wasting, mental confusion, and loss of family support.)
The severely disabled stroke patient needs two or three months of intensive team work in hospital and prolonged follow-up Cross-sensitivity between practolol and other beta-blockers ? SIR,-During 1974 and 1975 the Swedish Adverse Drug Reaction Committee received 95 reports of adverse reactions involving the skin and eyes following treatment with practolol. The causal relationship between the condition described in the reports and practolol was classified as "probable" or "not excluded" by the committee. When the possibility of a cross-reaction between practolol and other beta-blockers started to be discussed' inquiries were sent to the reporting physicians asking if their patients had been treated with other beta-blocking agents. Eighty-six answers were sent in and indicated that 64 of the 86 patients had received another beta-blocker to replace practolol. All betablocking agents on the Swedish market had been used, alprenolol in 26 cases, propranolol in 17, pindolol in 17, metoprolol in seven, and oxprenolol in three (six patients had received two drugs).
In six instances the symptoms thought to have been provoked by practolol either reappeared when another beta-blocker was administered (two patients) or failed to disappear in spite of the change of drug (four patients). Of the first two patients, one, a 70-year-old woman, got macular skin changes which had developed when she was taking practolol, disappeared when this drug was discontinued, but came back when alprenolol was administered one month later. The other, a man aged 56, had psoriasiform skin eruptions and complained of dry eyes. Both complaints vanished when practolol was discontinued. The eye symptoms reappeared when treatment with metoprolol was started some weeks later. Five months later a challenge test with metoprolol provoked the same eye symptoms. A test for antinuclear factor was negative. In the remaining four cases the symptoms remained in spite of a change from practolol to another beta-blocker (alprenolol, pindolol (two patients, or propranolol). Irritation of the eyes was described in three patients, one of whom also had cutaneous symptoms. The fourth patient had psoriasiform changes of the skin which did not improve when her medication was changed from practolol to pindolol. by mouth and her blood sugar before admission had been 5 5 mmol/l (100 mg/100 ml) on two occasions. The steroids were continued after admission and we found when we made numerous random blood sugar estimates that it could drop as low as 2-9 mmol/l (52 mg/100 ml). It was long ago pointed out2 that symptoms of hypoglycaemia might develop at higher levels of blood sugar in patients with Addison's disease than in normals and it seems likely that the same might be true in hypopituitary patients. We thought that in our patient the blood sugar may not have been maintained at a consistently normal level for long enough for the brain to recover after a prolonged period of hypoglycaemia. We therefore gave her regular and frequent glucose drinks and by the end of a week she was quite normal and remained so during follow-up. It 
